Epizyme, Inc.

Informe acción DB:EPE

Capitalización de mercado: €241.4m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Salud financiera de hoja de balance de Epizyme

Salud financiera controles de criterios 0/6

Información clave

-1,148.4%

Ratio deuda-patrimonio

US$232.91m

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$144.41m
Patrimonio-US$20.28m
Total pasivoUS$284.44m
Activos totalesUS$264.16m

Actualizaciones recientes sobre salud financiera

Recent updates

Análisis de la situación financiera

Pasivos a corto plazo: EPE has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Pasivo a largo plazo: EPE has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Historial y análisis de deuda-patrimonio

Nivel de deuda: EPE has negative shareholder equity, which is a more serious situation than a high debt level.

Reducción de la deuda: EPE's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: EPE has less than a year of cash runway based on its current free cash flow.

Pronóstico de cash runway: EPE has less than a year of cash runway if free cash flow continues to reduce at historical rates of 17.8% each year


Descubre empresas con salud financiera